Software/Technology

Over the past 10 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI’s IO Summit provides.

Where the new wave of life science innovators partner to fuel the future of drug development.

BIO-Europe Spring, the premier springtime partnering event, brings together over 3,700 attendees from 2,000+ companies to engage in 20,000 one-to-one meetings.

Connect and engage with a wide range of business leaders, including senior executives of leading biotech
companies, business development teams from pharmaceutical companies and other industry experts.

DPHARM is designed for drug development innovative thinkers who are determined to re-invent clinical trials. Going into its fifteenth year, the conference explores how clinical trials can be reimagined to be more efficient, more patient-focused, more accurate, quicker and less costly.  The conference has become highly regarded among executives at Pharma companies, Biotechs and CROs.

DIA’s Digital Technology in Clinical Trials Conference will bring together thought leaders from regulatory agencies, biotech, pharma, patients, and academia to discuss the latest advances, challenges, and forwardthinking approaches for implementing digital technology to improve clinical trials.

DIA has been the world’s leading member-based, non-profit organization driving innovation in patient safety and outcomes. We attract thousands of leading international life sciences organizations from Pharma, Biotech, Medical Device, and Diagnostic Equipment together with global regulatory agencies and leading academic researchers in a neutral, collaborative environment.

The Canada Annual Meeting will deliver a comprehensive overview of the current biopharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships, to key regulatory, clinical, and safety considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.

Our unparalleled annual gathering of the leading innovators, investors, payers, providers and policymakers who are driving the digital health revolution.

Join other leading innovators, investors, payers, providers, and policymakers as we continue to help revolutionize healthcare by discussing the most pertinent topics to the field.